Cns Pharmaceuticals Stock Forecast

Buy candidate since Jul 31, 2026

The CNS Pharmaceuticals, Inc. stock price gained 19.94% on the last trading day (Friday, 31st Jul 2026), rising from $4.85 to $5.82. During the last trading day the stock fluctuated 20.83% from a day low at $4.81 to a day high of $5.82. The price has fallen in 6 of the last 10 days but is still up by 15.42% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 10 thousand shares were bought and sold for approximately $57.70 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -14.19% during the next 3 months and, with a 90% probability hold a price between $3.04 and $5.77 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CNSP Signals & Forecast

The CNS Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.21 and $4.89. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 26, 2026, and so far it has risen 46.16%. Further rise is indicated until a new top pivot has been found. CNS Pharmaceuticals, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for CNS Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.52 and $5.22. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, CNS Pharmaceuticals, Inc. finds support just below today's level at $5.52. If this is broken, then the next support from accumulated volume will be at $5.22 and $4.89.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.00 between high and low, or 20.83%. For the last week, the stock has had daily average volatility of 6.34%.

Our recommended stop-loss: $5.60 (-3.80%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 24 days ago.)

Trading Expectations (CNSP) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect CNS Pharmaceuticals, Inc. to open at $5.48, and during the day (based on 14 day Average True Range), to move between $5.61 and $6.03, which gives a possible trading interval of +/-$0.418 (+/-7.45%) up or down from last closing price. If CNS Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 7.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.52 (5.11%) than the resistance at $6.90 (18.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is CNS Pharmaceuticals, Inc. stock A Buy?

CNS Pharmaceuticals, Inc. holds several positive signals and despite the stock being in a falling trend, we considered it to be a good choice at these current levels. We expect CNS Pharmaceuticals, Inc. stock will perform very well in the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Buy candidate.

Current score: 5.284 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $5.48 ( 5.75%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk